| Description | L6H9 is a novel inhibitor of myeloid differentiation factor 2 (MD2), suppressing HG-induced expression of ACE and AT1 receptor and Angiotensin II (AngII) production in renal NRK‐52E cells, resulting in the decrease in fibrosis markers such as TGF-β and collagen IV. |
| molecular weight | 274.26 |
| Molecular formula | C16H12F2O2 |
| CAS | 1345412-48-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |